Hong Kong stock unusual movement: SciClone Pharmaceuticals-B (02171.HK) rose more than 5%. The research results of CT0596 and CT1190B have been presented as poster presentations at the EHA annual meeting.

According to the Wise Wealth APP, Keji Pharmaceutical-B (02171.HK) rose more than 5%, as of the time of writing, it increased by 4.86% to 15.75 Hong Kong dollars, with a turnover of 86.1849 million Hong Kong dollars.